Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03375060 · ClinicalTrials.gov registry record
Histology Post-Endoscopic Eradication Therapy (EET)
A clinical trial, sponsored by Northwestern University.
- Completed
- Registry status
- 65
- Enrollment target
NCT03375060 is a clinical trial that has completed, run by Northwestern University. The registered enrollment target is 65 participants.
The verdict
NCT03375060 has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- 65 participants
- Enrollment target
Study Summary
This study is looking at a cohort of patients who have undergone treatment for Barrett's Esophagus (BE) and who have experienced complete eradication of the disease. The aim of the proposed study is to evaluate the histologic features of the neosquamous epithelium (NSE) following complete eradication of intestinal metaplasia (CE-IM) in patients undergoing routine surveillance biopsies and compare these data to a direct measure of reflux using 24hr pH impedance, to determine the correlation between histology and persistent reflux. These data will allow us to more accurately risk stratify patients for recurrence of BE following EET.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2017-08-02 |
| Est. Completion | 2017-11-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03375060
The ClinicalTrials.gov registry entry for NCT03375060 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03375060 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03375060 about?
NCT03375060 is a clinical study titled "Histology Post-Endoscopic Eradication Therapy (EET)". This study is looking at a cohort of patients who have undergone treatment for Barrett's Esophagus (BE) and who have experienced complete eradication of the disease. The aim of the proposed study is to evaluate the histologic features of the neosquamous epithelium (NSE) following complete eradicatio...
What is the current status of trial NCT03375060?
This trial is currently completed. The enrollment target is 65 participants. The study started on 2017-08-02. Estimated completion is 2017-11-05.
Who is sponsoring clinical trial NCT03375060?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.